Insider: Townsend Adam J. Chief Commercial Officer - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 84,050 | 0 | 84,050 |
| Value | $1,880,198.50 | $0.00 | $1,880,198.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/29/2025 | DDS | 695 | Direct | COM | $29.52 | $20,518.90 | 84,050 |
| 01/22/2025 | DDS | 3,323 | Direct | COM | $30.43 | $101,103.94 | 84,745 |
| 01/17/2025 | DDS | 2,201 | Direct | COM | $29.96 | $65,938.00 | 88,068 |
| 01/13/2025 | DDS | 2,685 | Direct | COM | $28.70 | $77,065.14 | 90,269 |
| 02/12/2024 | DDS | 1,148 | Direct | COM | $67.77 | $77,796.40 | 92,453 |
| 01/29/2024 | DDS | 906 | Direct | COM | $64.14 | $58,109.21 | 93,601 |
| 01/22/2024 | DDS | 3,413 | Direct | COM | $65.00 | $221,831.35 | 94,507 |
| 01/16/2024 | DDS | 2,235 | Direct | COM | $66.81 | $149,317.22 | 97,920 |
| 12/01/2023 | DDS | 67,557 | Direct | COM | $60.50 | $4,087,326.86 | 118,850 |
| 12/01/2023 | DDS | 42,443 | Direct | COM | $61.31 | $2,601,976.60 | 76,407 |
| 05/03/2023 | DDS | 5,000 | Direct | COM | $82.71 | $413,550.00 | 75,995 |
| 04/03/2023 | DDS | 5,000 | Direct | COM | $74.05 | $370,250.00 | 75,995 |
| 03/03/2023 | DDS | 5,000 | Direct | COM | $63.84 | $319,200.00 | 75,995 |
| 02/03/2023 | DDS | 5,000 | Direct | COM | $55.85 | $279,250.00 | 67,932 |
| 01/03/2023 | DDS | 5,000 | Direct | COM | $50.70 | $253,500.00 | 42,907 |
| 12/05/2022 | DDS | 5,000 | Direct | COM | $50.38 | $251,900.00 | 42,907 |
| 11/03/2022 | DDS | 5,000 | Direct | COM | $58.54 | $292,700.00 | 42,907 |
| 10/03/2022 | DDS | 5,000 | Direct | COM | $66.69 | $333,450.00 | 42,907 |
| 09/06/2022 | DDS | 5,000 | Direct | COM | $60.38 | $301,900.00 | 42,907 |
| 08/15/2022 | DDS | 12,500 | Direct | COM | $69.00 | $862,500.00 | 42,907 |
| 08/11/2022 | DDS | 12,500 | Direct | COM | $67.00 | $837,500.00 | 42,907 |
| 08/08/2022 | DDS | 12,500 | Direct | COM | $65.00 | $812,500.00 | 42,907 |
| 08/03/2022 | DDS | 5,000 | Direct | COM | $56.43 | $282,150.00 | 37,907 |
| 07/11/2022 | DDS | 5,000 | Direct | COM | $48.42 | $242,100.00 | 42,907 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research